| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030905A1 Dihydroorotate dehydrogenase inhibitor |
| 04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
| 04/17/2003 | WO2000010990A3 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073825 Azalide antibiotic compositions |
| 04/17/2003 | US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens |
| 04/17/2003 | US20030073699 Compounds and methods to treat cardiac failure and other disorders |
| 04/17/2003 | US20030073667 Solvent system containing mixture of terpene and alkylene glycol ethers |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2461145A1 Live attenuated salmonella strains for producing vaccines |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458446A1 Cyanoacetyl compounds |
| 04/17/2003 | CA2455999A1 Carbonyloxy-cyanomethyl compounds as antiparasitic agents |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301188A2 Anthelmintic agents for preventing parasitic infections in humans and animals iii |
| 04/16/2003 | EP1301185A2 Anthelminthic agents for the prevention of parasitic infections in humans and animals |
| 04/16/2003 | EP1301150A1 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411337A Anthelmintic compositions |
| 04/16/2003 | CN1410104A Agent for preventing and treating aquatic animal parasitic disease |
| 04/16/2003 | CN1410060A 苦参碱阴道凝胶 Matrine vaginal gel |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/15/2003 | US6548521 Use of aromatic a,b-unsaturated ketone derivatives treating malaria, schistosomiasis and other infectious diseases |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 04/10/2003 | WO2003028736A2 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised |
| 04/10/2003 | WO2003028701A2 Liposomes containing (ether)lysolecithins |
| 04/10/2003 | WO2003028630A2 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | WO2003028459A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 04/10/2003 | WO2003007971A9 Improved heteropolymer complexes and methods for their use |
| 04/10/2003 | WO2003002115A3 Substituted benzimidazoles for controlling endoparasites |
| 04/10/2003 | WO2003000118A3 Method for enhancing the effectiveness of cancer therapies |
| 04/10/2003 | WO2002008396A3 Human proteases |
| 04/10/2003 | WO2001058480A3 Tubulin based vaccine against trypanosomiasis |
| 04/10/2003 | US20030069243 Novel substituted imidazole compounds |
| 04/10/2003 | US20030068393 Soaking the roots of the Nauclea Latifolia plant in potable alcohol to obtain an infusion, separting the roots form the plant extract by filtration or decantation, thus forming antimaleria agent |
| 04/10/2003 | US20030068328 Live attenuated salmonella strains for producing monovalent or multivalent vaccines |
| 04/10/2003 | US20030068315 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP0881881B1 Antiparasitic composition for treating and protecting pets |
| 04/09/2003 | EP0804552B1 Redirection of cellular immunity by receptor chimeras |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409635A Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
| 04/08/2003 | US6544780 Adenovirus vector with multiple expression cassettes |
| 04/08/2003 | US6544551 Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis |
| 04/08/2003 | US6544530 Stable oil-in-glycerin emulsion |
| 04/08/2003 | US6544518 Vaccines |
| 04/03/2003 | WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027058A1 Sphingolipids |
| 04/03/2003 | WO2003026663A1 Process for making substituted pyrazoles |
| 04/03/2003 | WO2003026633A1 Natural pharmaceutical composition against parasitosis in bees |
| 04/03/2003 | WO2002100418B1 Exothermic formulations for the treatment of ectoparasites |
| 04/03/2003 | WO2002092563A3 Protease inhibitors |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | US20030064369 Novel proteins and nucleic acids encoding same |
| 04/03/2003 | US20030064097 For delivery of drugs, nutrionals, cosmeceuticals and diagnostic agents |
| 04/03/2003 | US20030064075 For diagnosis, therapy and prophylaxis of malaria; vaccines |
| 04/03/2003 | US20030064064 Administering formulation that inhibits activity of IgE(immunoglobulin E) sufficient to decrease the activity of IgE and administering to the subject second formulation amount of the antigen sufficient to modulate the immune response |
| 04/03/2003 | CA2820170A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/03/2003 | CA2461801A1 Sphingolipids |
| 04/03/2003 | CA2461095A1 Process for making substituted pyrazoles |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2459807A1 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/02/2003 | EP1298208A2 Ribozymes targeting a hiv tat sequence |
| 04/02/2003 | EP1298138A1 Carbamate and Carbazate Ketolide Antibiotics |
| 04/02/2003 | EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296699A1 Therapeutic agents - iii |
| 04/02/2003 | EP1296698A1 Therapeutic agents - ii |
| 04/02/2003 | EP1296697A1 Therapeutic agents - i |
| 04/02/2003 | EP1296686A2 Praziquantel compositions for treating diseases due to sarcocystis, neospora, toxoplasma and isospora |
| 04/02/2003 | EP1296670A1 Therapeutic combinations of fatty acids |
| 04/02/2003 | EP1296655A1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP0716697B1 DIFFERENTIALLY EXPRESSED $i(LEISHMANIA) GENES AND PROTEINS |
| 04/02/2003 | CN1407893A Triazinone compounds for treating diseases resulting from infretation with parasitic protozoans |
| 04/02/2003 | CN1406584A Gel composition for killing parasites |
| 04/02/2003 | CN1104434C Optical pure analogs of camptothecinum and composition and use thereof |
| 04/02/2003 | CN1104245C Method for treating pesticide residue in ginseng and other Chinese herbal medicine extract |
| 04/01/2003 | US6541508 Water solubility; prodrug containing polyether oligomer |
| 04/01/2003 | CA2273951C Parasiticidal pyrazoles |
| 03/27/2003 | WO2003025542A2 Immune response associated proteins |
| 03/27/2003 | WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |